Utility of absolute and relative changes in cardiac troponin concentrations in the early diagnosis of acute myocardial infarction. Circulation. 2011;124:136 45. 71. Apple FS, Smith SW, Pearce LA, et al. Delta changes for optimizing clini- cal specificity and 60-day risk of adverse events in patients presenting with symptoms suggestive of acute coronary syndrome utilizing the ADVIA Centaur Tnl-Ultra assay. Clin Biochem. 2012;45:711 3. 72. Santalo M, Martin A, Velilla J, et al. Using high-sensitivity troponin T: the importance of the proper gold standard. Am J Med. 2013;126:709 17. 73. Apple FS, Pearce LA, Smith SW, et al. Role of monitoring changes in sensi- tive cardiac troponin I assay results for early diagnosis of myocardial infarc- tion and prediction of risk of adverse events. Clin Chem. 2009;55:930 7. 74. Hammarsten O, Fu ML, Sigurjonsdottir R, et al. Troponin T percentiles from a random population sample, emergency room patients and patients with myocardial infarction. Clin Chem. 2012;58:628 37. 75. Pollack CV Jr., Sites FD, Shofer FS, et al. Application of the TIMI risk score for unstable angina and non-ST elevation acute coronary syndrome to an unselected emergency department chest pain population. Acad Emerg Med. 2006;13:13 8. 76. Go J, Narmi A, Sype J, et al. Impact of renal dysfunction on the prognostic value of the TIMI risk score in patients with non-ST elevation acute coro- nary syndrome. Coron Artery Dis. 2011;22:411 5. 77. Huynh T, Nasmith J, Luong TM, et al. Complementary prognostic val- ues of ST segment deviation and Thrombolysis In Myocardial Infarction (TIMI) risk score in non-ST elevation acute coronary syndromes: Insights from the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) study. Can J Cardiol. 2009;25:e417 21. 78. Eagle KA, Lim MJ, Dabbous OH, et al. 